Most conjugative R plasmids replicate under stringent control and therefore occur as one or two copies per chromosome (21) . The transferable plasmid R6K, which confers resistance to ampicillin and streptomycin, is unusual because it replicates under relaxed control and so occurs as 10 to 40 copies per chromosome (12) . Various chemicals eliminate plasmids from their bacterial hosts (6, 7) . Most common among these are the acridines and other intercalating drugs, which are believed to exert their effects by disrupting plasmid replication (8, 20, 27) . As the DNA strand-breaking activity of bleomycin (BLM) (13-15, 23, 24) is preceded by the intercalation of the drug into duplex DNA (19) , we tested its plasmid-eliminating activity.
Escherichia coli AB1157 (F-thi-l his4 proA2 argE3 thr-J leuB6 ara-14 lacYl galK2 xyl-S mtl-l supE44 tsx-33 rpsL31) (2) was used as the host strain for plasmids RI, R46, and R6K (22) . Strains were routinely grpwn at 37°C in nutrient broth or on nutrient agar (1) . The method used for testing sensitivities to BLM has been described previously (1) . Plasmid R6K sensitized E. coli AB1157 to a sublethal dose of BLM but had much less of an effect at a lethal drug concentration (Fig. 1 ). This phenomenon is R6K specific, as the two low-copy plasmids Rl and R46 failed to sensitize this strain to BLM, and AB1157 clones from which R6K was eliminated showed resistance to the drug that was similar to that of the original R-strain (P. V. Attfield The elimination of R6K by BLM is unlikely to be due simply to the selection of R-segregants in the AB1157(R6K) population. Inocula of 105 cells were used in the subculturing technique; given that R-cells divide almost twice as fast as R6K-carrying cells in 0.1 ixg of BLM per ml (Fig. 1) , if only one R-cell was present in the original inoculum, then Rcells should have been detected after only 75 generations instead of over 300 generations (Fig. 2) . The fact that R6K is a multicopy plasmid, together with the observed pattern of elimination (Fig. 2) , suggests that BLM causes a gradual decline in R6K copy number. One way to test this was to quantify a phenotypic trait of R6K that relates directly to the number of encoding genes and therefore to plasmid copy number. Exponential-or stationary-phase E. coli strains harboring R6K show a close correlation betweenlactamase activity and plasmid copy number (12, 16) . Therefore, total 1-lactamase activities in cell extracts and supernatants from both BLM-treated and nontreated cultures were assayed by the hydroxylamine method (5) . No 1-lactamase activity was detected in the R-strain (data not shown), whereas nontreated cultures of AB1157(R6K) had consistently high levels of enzyme activity, ranging from 992 to 1,391 mU/109 cells (where 1 mU is the amount of ,B-lactamase required to hydrolyze 0.001 mmol of benzylpenicillin per min at 37°C in 25 mM sodium phosphate buffer [pH 7.4]). When strain AB1157(R6K) was grown continuously in 0.1 jig of BLM per ml, there was a steady decline in 13-lactamase activity throughout the treatment period (Fig.  2) , suggesting that the drug does cause a gradual reduction in R6K copy number during prolonged exposure.
The effect of BLM on R6K copy number was studied more directly by subculturing 0.2-ml samples of strain AB1157(R6K) grown continuously in the absence or pres-ANTIMICROB. AGENTS CHEMOTHER. copy number which was directly proportional to the number of generations in the presence of the drug (Fig. 3) .
The plasmid CCC copy number was under 1 per chromosome after 300 generations in the presence of BLM (Fig. 3) , whereas at the same time 3-lactamase activity was reduced to only 30%o of control levels, and R-clones were not observed for a further 75 generations (Fig. 2) (50 Ci/mmol) per ml. After 2 h of incubation, cells were lysed and sheared before being centrifuged at 180,000 x g and 20°C for 60 min through 12.5-ml linear 5 to 20o (wt/vol) alkaline sucrose gradients by techniques described previously (18) . This process separated covalently closed circular (CCC) plasmid molecules from chromosomal DNA fragments and enabled plasmid copy number to be calculated by comparison of the total amount of acid-insoluble radioactivity in CCC plasmid peaks with that in the corresponding chromosomal DNA peaks. Calculations were based on the facts that the E. coli chromosome has a molecular weight of 2.5 x 109 and a 50% guanine-plus-cytosirne content, whereas R6K has a molecular weight of 2.6 x 107 and a 45% guanine-plus-cytosine content (4, 12) . Control (nontreated)
cultures showed a constant copy number of about 10 CCC molecules per chromosome throughout the duration of the experiment (Fig. 3 ). This value is in close agreement with those reported by other workers (12, 16 terms of the respective requirements of low-and high-copy plasmids for host DNA polymerase functions. R6K and multicopy plasmids in general show a requirement for polymerase I during replication (21, 25, 26) , whereas low-copy plasmids replicate independently of this enzyme, utilizing polymerase III (17, 21) . Polymerase I is essential for the repair of DNA strand gaps (3, 9) , and its availability for replicative synthesis is therefore likely to be reduced in cells that have been exposed to the DNA strand-breaking drug BLM. This could well lead to a fall in R6K copy number and eventual plasmid elimination. As low-copy plasmids do not require polymerase I activity for replication, there is no competition between repair and replicative DNA polymerase functions in cells exposed to BLM. The drug would therefore not be expected to have an effect on the stability of low-copy plasmids. Competition between the chromosome and plasmid genomes for the DNA repair and replicative activities of polymerase I could also explain why the multicopy plasmid, but not the low-copy plasmids, sensitized dividing cells to BLM.
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